Andrew Berchuck, MD
Gynecologic Oncology · Durham, NCNPI 1154349181
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,046 of the $12,293 with a category attached, or 98.0%. Organon accounts for 98.0% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $12,088 and has fallen 99.9% since, to $14 in 2025.
Across 10 payments — averaging $1229.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$12K
- Aadi Bioscience, Inc.$100
- Myriad Genetic Laboratories, Inc.$42
- Merck$32
- Covidien LP$31
- Genentech USA, Inc.$16
- plus $27 from 2 others
What the payments were for
- Consulting fees$12,04698%
- Food & beverage$2292%
- Education$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 2 | $12,046 |
| Aadi Bioscience, Inc. | 1 | $100 |
| Myriad Genetic Laboratories, Inc. | 1 | $42 |
| Merck | 2 | $32 |
| Covidien LP | 1 | $31 |
| Genentech USA, Inc. | 1 | $16 |
| Myovant Sciences Inc. | 1 | $14 |
| Amgen | 1 | $13 |
How this compares
$12,293 in reported general payments places this provider in the 80th percentile of 52 gynecologic oncology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 14 | $333 |
| Prochlorperazine Maleate | 18 | $105 |
| Ondansetron Hcl | 15 | $94 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Durham
- Angeles SecordDurham$121K
- William LoweryDurham$67K
- Haley MossDurham$2K
- Laura HavrileskyDurham$29
- Lucybeth Nieves ArribaWilmington$251K
- Robert NaumannCharlotte$221K
- Erin CraneCharlotte$98K
- Michael SundborgSouthern Pines$85K
- Emma RossiGreensboro$62K
- Jubilee BrownCharlotte$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.